Sign Up Today and Learn More About Aerami Therapeutics Stock
Invest in or calculate the value of your shares in Aerami Therapeutics or other pre-IPO companies through EquityZen's platform.
Aerami Therapeutics Stock (AETH)
Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases.
About Aerami Therapeutics Stock
Founded
2010
Headquarters
Durham, NC, US
Industries
Software, Artificial Intelligence, Data and Analytics
Aerami Therapeutics Press Mentions
Stay in the know about the latest news on Aerami Therapeutics
Aerami Therapeutics Presents New Lung Deposition Modeling Data For AER-901 in Pulmonary Hypertension at the American Thoracic Society 2024 International Conference
finance • Aug 03, 2024
Aerami Therapeutics to Present New Lung Deposition Modeling Data for AER-901, in Development for Pulmonary ...
finance • Jul 04, 2024
Aerami Therapeutics to Present New Lung Deposition Modeling Data for AER-901, in Development for Pulmonary ...
globenewswire • May 23, 2024
Aerami Therapeutics to Present Data Supporting AER-901 Dosing Regimen at CHEST 2023
finance • Feb 23, 2024
RTP's United Therapeutics makes $91M deal to buy Miromatrix Medical
bizjournals • Dec 21, 2023
Aerami Therapeutics Management
Leadership team at Aerami Therapeutics
Chairman, CEO & Founder
John S. Patton
Board Member & Audit Committee Chair
Darlene Deptula-Hicks
Join now and verify your accreditation status to gain access to:
- Aerami Therapeutics current valuation
- Aerami Therapeutics stock price
- Available deals in Aerami Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Aerami Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Aerami Therapeutics through EquityZen funds. These investments are made available by existing Aerami Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aerami Therapeutics stock?
Shareholders can sell their Aerami Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
